TEHRAN – Secretary of the 
Biotechnology Development Headquarters in the Vice Presidency of Science and Technology Mostafa Ghanei has announced that the country has exported biotechnology drugs to 17 countries in the world.
He put the current value of the nanotechnology medicines exported from Iran to other countries at above $200 million.
He went on to say that the administration of President Pezeshkian is trying to localize the largest high-value products, including insulin and plasma, within the next two years and solve the existing problem.
Some 45 Iranian pharmaceutical companies are presently producing biotech products in the country. 
The global market of biotech drugs are expected to hit $900 billion by 2030, as he expressed hope that Iranian companies could increase their share of the global trade for those drugs.